Nien-Tsu Chen

Nien-Tsu Chen has extensive work experience in the pharmaceutical industry. From 2011 to 2016, they worked at Pharmaessentia Corporation as a Senior Scientist. In this role, they conducted research and analysis in the field of bioassay and bioanalytics. From 2016 to 2019, they transitioned to the position of Supervisor for Bioassay and Bioanalytics at the same company. Here, they were responsible for overseeing a team and managing projects in this area. In 2019, Nien-Tsu Chen joined Mello Biotech as a Director. They held this position until 2022, where they worked on various projects and contributed to the overall strategic activities of the company. Nien-Tsu Chen is currently the Director of Key Project Management at Polaris Pharmaceuticals, a position they started in 2022.

Nien-Tsu Chen's education history showcases a strong academic background. Nien-Tsu earned their Bachelor's degree in Agricultural Chemistry from National Taiwan University, where they studied from 1992 to 1996. Following this, they pursued a Master's degree in Food Science and Technology from the same university, completing their studies in 1998. Later on, Nien-Tsu Chen went on to the University of California, Davis, where they obtained their Doctor of Philosophy (PhD) in Comparative Pathology. Nien-Tsu pursued their doctoral studies from 2005 to 2011.